Informa (LSE: INF.L), the international B2B Markets, Knowledge Services and Business Intelligence Group today announced two significant steps in its 2021-2024 Growth Acceleration Plan II (“GAP II”). The Group has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division